Special notice
Metabolomic Profiles and Pancreatic Cancer Risk in
75N91024Q00027
National Institutes of Health, NIH NCI. Research and Development in Biotechnology (except Nanobiotechnology).
Response deadline
January 17, 2024 at 3:00 PM EST
Closed 974 days ago. Posted January 10, 2024. Scheduled to archive February 1, 2024.
Description
As published on SAM.gov.
The U.S. Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Metabolic Epidemiology Branch (MEB), Division of Cancer Epidemiology and Genetics (DCEG), plans to procure services, on a sole source basis, from the Metabolon, Inc., 617 Davis DR STE 400, Morrisville, North Carolina 27560-7171.
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
January 10, 2024
Special notice
Due January 17, 2024 at 3:00 PM EST. SAM.gov, notice f432871f6de34d16b10b104b812e625c
Points of contact
- SUMMONS, DANA Adana.summons@nih.gov+1 240 276 5319
Also open from this buyer
- NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT PHASE I AWARD PROGRAMSolicitationSmall businessNAICS 5417175N98026R00109Closes in 4 daysSep 21